Pubertal Suppression for Transgender Youth and Risk of Suicidal Ideation
2020; American Academy of Pediatrics; Volume: 145; Issue: 2 Linguagem: Inglês
10.1542/peds.2019-1725
ISSN1098-4275
AutoresJack L. Turban, Dana King, Jeremi M. Carswell, Alex S. Keuroghlian,
Tópico(s)Sexuality, Behavior, and Technology
ResumoGonadotropin-releasing hormone analogues are commonly prescribed to suppress endogenous puberty for transgender adolescents. There are limited data regarding the mental health benefits of this treatment. Our objective for this study was to examine associations between access to pubertal suppression during adolescence and adult mental health outcomes.
Referência(s)